[Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213]

Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.

Anti-cancer drugs·1992

Retrospective study correlating clinical infectious history and peripheral blood T-cell subpopulations in cancer, GvH and HIV+ patients.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992

Radical tumor excision and cosmetic balance in the surgical treatment of breast carcinoma: biquadrantectomy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992

Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.

Cancer detection and prevention·1992

Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.

Drugs under experimental and clinical research·1992

Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1991

Hospitalization at home use analysis for immune checkpoint inhibitors administrations in France: Care pathways, costs and development opportunities.

Bulletin du cancer·2026

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Bulletin du cancer·2026

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

Bulletin du cancer·2026

French treatment recommendations for malignant non-seminomatous germ cell tumours in children and adolescents.

Bulletin du cancer·2026

A comprehensive review on the molecular basis and therapeutic potential of UBE2M in cancer.

Bulletin du cancer·2026

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Bulletin du cancer·2026

Efficacy and safety of daratumumab-based quadruplet therapy vs non-daratumumab-based triplet therapy in newly diagnosed multiple myeloma patients: A GRADE assessed systematic review and meta-analysis of randomized controlled trials.

Therapeutic advances in hematology·2026

Targeted AAV gene therapy for neuroblastoma via direct capsid-antibody coupling.

EMBO molecular medicine·2026

Exogenous melatonin alleviates liver injury via regulating hepatocellular PI3K/AKT pathway and inhibiting NLRP3 activation.

European journal of pharmacology·2026

A therapeutic atlas of monogenic inflammatory bowel disease.

Journal of Crohn's & colitis·2026

German Delphi consensus: COMT inhibitors in the management of wearing-off fluctuations in Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Interventional management of acute mesenteric venous thrombosis: a systematic review of current evidence, emerging techniques and future perspectives.

Abdominal radiology (New York)·2026

Related Experiment Videos

[Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213]

Related Concept Videos

Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.

Retrospective study correlating clinical infectious history and peripheral blood T-cell subpopulations in cancer, GvH and HIV+ patients.

Radical tumor excision and cosmetic balance in the surgical treatment of breast carcinoma: biquadrantectomy.

Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.

Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.

Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia.

Hospitalization at home use analysis for immune checkpoint inhibitors administrations in France: Care pathways, costs and development opportunities.

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

French treatment recommendations for malignant non-seminomatous germ cell tumours in children and adolescents.

A comprehensive review on the molecular basis and therapeutic potential of UBE2M in cancer.

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Efficacy and safety of daratumumab-based quadruplet therapy vs non-daratumumab-based triplet therapy in newly diagnosed multiple myeloma patients: A GRADE assessed systematic review and meta-analysis of randomized controlled trials.

Targeted AAV gene therapy for neuroblastoma via direct capsid-antibody coupling.

Exogenous melatonin alleviates liver injury via regulating hepatocellular PI3K/AKT pathway and inhibiting NLRP3 activation.

A therapeutic atlas of monogenic inflammatory bowel disease.

German Delphi consensus: COMT inhibitors in the management of wearing-off fluctuations in Parkinson's disease.

Interventional management of acute mesenteric venous thrombosis: a systematic review of current evidence, emerging techniques and future perspectives.

Related Experiment Videos

[Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213]

Related Concept Videos

Related Articles